Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Janssen’s Symtuza scores approval with the FDA in HIV-1

July 18, 2018 Sales and Marketing HIV, Janssen, Symtuza, pharma

Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …
News

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018 Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …
News

AbbVie and Mylan reach US marketing agreement for Humira biosimilar

July 18, 2018 Research and Development, Sales and Marketing AbbVie, Humira, Mylan, US, pharma

AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of …
News

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
Appointment

Senate claims Novartis misled public on Trump lawyer deal

July 16, 2018 Sales and Marketing Novartis, Senate, Trump, United States, deal

A report released by the United States Senate has found that Novartis’ relationship with Donald Trump’s long-time lawyer Michael Cohen …
News

Recruitment and retention: How can we do better?

July 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …
Feature

FDA expands Pfizer and Astellas’ Xtandi into castration-resistant prostate cancer

July 16, 2018 Sales and Marketing Astellas, Cancer, FDA, Pfizer, US, Xtandi, pharma, prostate cancer

Astellas and Pfizer have revealed that their androgen receptor inhibitor Xtandi (enzalutamide) has received approval from the FDA to expand …
News

FDA approves first smallpox therapy to defend against bioterrorism

July 16, 2018 Sales and Marketing FDA, pharma, smallpox

The FDA has announced that it has awarded marketing authorisation to SIGA Technologies’ TPOXX (tecovirimat) in the first approval of …
News

European cannabis market set to be worth €115.7 billion by 2028

July 16, 2018 Sales and Marketing Europe, Legislation, cannabis, medicinal marijuana

The European cannabis market is set to be worth €115.7 billion by 2028, according to a report released by the …
News

Indivior shares soar as US judge rules against Dr Reddy

July 16, 2018 Sales and Marketing

Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories …
News

Top Ten most popular articles on Pharmafile.com this week

July 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Pfizer, Sanofi, Trump, top 10

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …
News

Otsuka snaps up Visterra in $430 million deal

July 12, 2018 Research and Development, Sales and Marketing Otsuka, Visterra, acquisition, pharma

Otsuka Pharmaceutical has announced it has reached a definitive, board-approved agreement with Visterra to acquire the latter company in an …
News

Pfizer restructures in preparation for potential sell off

July 12, 2018 Sales and Marketing Pfizer, bisoimilar, consumer, health

Pfizer has announced plans to reorganise into three separate units through the separation of its consumer health care business from …
News

Novartis pulls out of antibiotics, cuts 140 staff

July 12, 2018 Sales and Marketing Antibiotics, Novartis, pharma, staff cuts

Novartis has announced that it is to terminate its research operations into antibiotics and antivirals in a reorganisation effort that …
News

NICE approves treatment for rare and deadly childhood cancer

July 11, 2018 Sales and Marketing Cancer, NICE, UK, neuroblastoma, pharma

NICE has recommended that monoclonal antibody dinutuximab beta be used in treating high-risk neuroblastoma – a rare and deadly form …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026